BCG
LLY icon

Bravias Capital Group’s Eli Lilly LLY Stock Holding History

Bravias Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+182
New +$186K 0.13% 95
2026
Q1 		– Sell
-300
Closed -$322K – 106
2025
Q4 		$322K Sell
300
-6
-2% -$5.74K 0.19% 80
2025
Q3 		$233K Buy
306
+45
+17% +$33.5K 0.16% 92
2025
Q2 		$203K Buy
261
+10
+4% +$7.77K 0.15% 98
2025
Q1 		$207K Hold
251
– – 0.17% 80
2024
Q4 		$203K Buy
+251
New +$208K 0.17% 97

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bravias Capital Group's LLY Position: Q2 2026 in Review

Bravias Capital Group opened a new position in Eli Lilly (LLY) in Q2 2026: 182 shares worth $218K. The stake represents 0.13% of the portfolio and ranks #95 among its holdings. This is a return to the name: Bravias Capital Group previously reported a position in LLY as recently as Q4 2025.

Bravias Capital Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $322K in Q4 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bravias Capital Group held 182 shares of Eli Lilly worth $218K as of Q2 2026.
  • Eli Lilly was a new Bravias Capital Group position in Q2 2026.
  • Eli Lilly made up 0.13% of Bravias Capital Group's portfolio in Q2 2026, its #95 holding.
  • Bravias Capital Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Bravias Capital Group's Eli Lilly position peaked at $322K in Q4 2025.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bravias Capital Group's 13F filing for Q2 2026, filed 30 Jul 2026.